Adjunct Associate Professor of Epidemiology
Harvard T.H. Chan School of Public Health
Harvard School of Public Health
Kresge Bldg, RM 911
677 Huntington Ave
Boston MA 02115
|Karolinska Institutet, Stockholm, Sweden||MD||06/2002||Medicine|
|Karolinska Institutet, Stockholm, Sweden||PhD||06/2011||Medical Science|
|Harvard T.H. Chan School of Public Health, Boston, USA||MPH||06/2009||Quantitative Methods|
Dr Anna Sara Oberg is an adjunct Associate Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, with primary affiliation in the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet. Interested in the causes and consequences of reproductive challenges, her research spans across the whole the range of sensitive periods from pre-conception through pregnancy up to labour and delivery, and concerns the health of both mother and child. Current efforts center on the safety of assisted reproductive practices, through long-term evaluations of children, and more recently the influence on women's cardiovascular health. Dr Oberg is additionally leading an effort to enable and improve the use of national registers to study prescribed drug use in relation to reproduction, through a new extensive linkage and advanced methods of data extraction that will allow more detailed exposure characterisation. As the first curriculum fellow in the online/on-campus MPH in Epidemiology Dr Oberg was closely involved in the program development and launch in 2015, and she has since continued to contribute as an instructor in Analytic Methods for Epidemiologists and as a member on the Practicum Committee.
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
to make corrections and additions.
Jan 1, 2021 - Dec 30, 2023
Forte (Swedish Research Council for Health, Working Life and Welfare
Nationwide mapping of the use of fertility drugs and their impact on women’s cardiovascular health
Role Description: The goal is to characterize the use of fertility drugs in Sweden and comprehensively evaluate their relation to women’s risk of thromboembolic and cardiovascular disease.
Role: Principa Investigator
(D'ONOFRIO, BRIAN M)
Apr 1, 2019 - Feb 28, 2022
Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes
Role: Co-Principal Investigator
Mar 1, 2019 - Feb 28, 2022
Maternal use of prescribed opioid analgesics in pregnancy and risk of adverse offspring outcomes
Role Description: The goal is to advance understanding of the use and safety of prescribed opioids in pregnancy, focusing on adverse birth outcomes and offspring neurodevelopment, using Swedish population (register) data
Role: Principal Investigator (shared)
Jan 1, 2019 - Dec 31, 2021
Prescribed opioid analgesics during pregnancy and risk for adverse birth outcomes and neurodevelopmental problems in offspring
Role Description: The goal is to identify psychosocial predictors of maternal use of opioid analgesics in pregnancy, and to evaluate the extent such may be responsible for observed associations to offspring adverse outcomes.
Role: Co-Investigator turned Principal Investigator
Sep 2, 2017 - Nov 30, 2022
Long Term Impact of Fertility Treatments (LIFT) Study
Role Description: The goal is to examine the long-term impact on children born from fertility treatments including assisted reproductive technology (ART) using data from Denmark, the Netherlands, Sweden, and the United States
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).